 The drug was patented at CIBA, which merged with Geigy into Ciba-Geigy, and eventually becoming Novartis.Where and when it is/was in common use, tripelennamine is used much like other mildly-anticholinergic antihistamines for treating conditions of the upper respiratory tract arising from illnesses and hay fever.It can be used alone or in combination with other agents to have the desired effect.